Related Experiment Video
Updated: Aug 30, 2025

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
Published on: May 17, 2024
A Unique Observation of a Patient with Vulto-van Silfhout-de Vries Syndrome
Natalia Bodunova1, Maria Vorontsova2, Igor Khatkov1
1The Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Abstract:
Introduction: Vulto-van Silfhout-de Vries Syndrome (VSVS; OMIM#615828) is a rare hereditary disease associated with impaired intellectual development and speech, delayed psychomotor development, and behavioral anomalies, including autistic behavioral traits and poor eye contact. To date, 27 patients with VSVS have been reported in the literature. Materials and Methods: We describe a 23-year-old male patient with autism spectrum disorder (ASD) who was admitted to the gastroenterological hospital with signs of pseudomembranous colitis. ASD was first noted in the patient at the age of 2.5 years. Later, he developed epileptic seizures and important growth retardation. Prior to the hospitalization, chromosomal aberrations, Fragile X syndrome, and aminoacidopathies/aminoacidurias associated with ASD were excluded. Whole-genome sequencing (WGS) was prescribed to the patient at 23 years old. Results: The patient had a heterozygous carrier of “de novo” variant c.662C > T (p.S221L) in exon 4 of the DEAF1 gene. c.662C > T had not been previously described in genomic databases. According to the ACMG criteria, this missense variant was considered to be pathogenic. VSVS was diagnosed in the patient. Conclusions: The phenotype of the patient is very similar to the data presented in the world literature. However, growth retardation and cachexia, which have not been described previously in the articles, are of interest.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Prosopagnosia
Mitral Stenosis II: Clinical features and Diagnostic Tests
Visual Agnosia
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies VII: Vascular Imaging

